Optimising the Caravaggio score: developing a more universally applicable and comprehensive venous thromboembolism risk stratification tool. Author’s reply

Maria Cristina Vedovati; Giancarlo Agnelli

doi:10.1016/j.ejim.2025.106561

Related publications

Article2025

Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

Maria Cristina Vedovati, Andrés J. Muñoz Martín, Michela Giustozzi, Paula Jiménez‐Fonseca, Cecilia Becattini, María Purificación Martínez del Prado, Francesco Dentali, Menno V. Huisman, Alexander T. Cohen, Rupert Bauersachs, Alberto Carmona‐Bayonas, Giancarlo Agnelli

Letter2012

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Melina Verso, Giancarlo Agnelli, Sandro Barni, Giampietro Gasparini, Roberto Labianca

Internal and Emergency Medicine

Article2021

Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study

Michela Giustozzi, Jean M. Connors, Ana Blanco, Sebastian Szmit, Nicolas Falvo, Alexander T. Cohen, Menno V. Huisman, Rupert Bauersachs, Francesco Dentali, Cecilia Becattini, Giancarlo Agnelli

Article2018

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment

Joshua D. Brown, Amie Goodin, Professor Gregory Lip, Val R. Adams

Article2010

A NEW TOOL FOR THE RISK STRATIFICATION OF PATIENTS WITH COMPLEX CORONARY ARTERY DISEASE: THE CLINICAL SYNTAX SCORE

Scot Garg, Giovanna Sarno, Chrysafios Girasis, Héctor M. García‐García, Joanna J. Wykrzykowska, Keith D. Dawkins, Patrick W. Serruys

Journal of the American College of Cardiology